Artwork

Content provided by Dr. Rod Berger. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Rod Berger or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

"Revolutionizing Healthcare: Dr. Matthias Bernow's Journey to Unlock the Transformative Power of Stem Cells" with Dr. Mattias Bernow of Cellcolabs

41:44
 
Share
 

Manage episode 468830763 series 3531594
Content provided by Dr. Rod Berger. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Rod Berger or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Dr. Matthias Bernow is not just a seasoned medical professional and CEO of Cellcolabs; he's also a visionary at the intersection of healthcare innovation and practical application. With roots deeply embedded in Stockholm and balancing roles as a businessman and a caring father, Dr. Bernow's mission is more than transactional: crafting a future where advanced medical treatments are accessible and impactful worldwide.

In our discussion, Dr. Bernow illuminates the current landscape of stem cell research, describing it as a pivotal moment, much like a thrilling midpoint in a great saga—full of potential yet uncertain outcomes. He parallels historical medical breakthroughs like antibiotics, suggesting that stem cells might similarly transform our approach to chronic diseases and aging. According to Dr. Bernow, stem cells offer three key benefits: anti-inflammatory properties, regenerative capabilities, and the ability to modulate the immune system. These attributes could revolutionize treatments for many conditions, from arthritis to diabetes, and perhaps fundamentally alter how we manage aging and chronic diseases.

  continue reading

94 episodes

Artwork
iconShare
 
Manage episode 468830763 series 3531594
Content provided by Dr. Rod Berger. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Rod Berger or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Dr. Matthias Bernow is not just a seasoned medical professional and CEO of Cellcolabs; he's also a visionary at the intersection of healthcare innovation and practical application. With roots deeply embedded in Stockholm and balancing roles as a businessman and a caring father, Dr. Bernow's mission is more than transactional: crafting a future where advanced medical treatments are accessible and impactful worldwide.

In our discussion, Dr. Bernow illuminates the current landscape of stem cell research, describing it as a pivotal moment, much like a thrilling midpoint in a great saga—full of potential yet uncertain outcomes. He parallels historical medical breakthroughs like antibiotics, suggesting that stem cells might similarly transform our approach to chronic diseases and aging. According to Dr. Bernow, stem cells offer three key benefits: anti-inflammatory properties, regenerative capabilities, and the ability to modulate the immune system. These attributes could revolutionize treatments for many conditions, from arthritis to diabetes, and perhaps fundamentally alter how we manage aging and chronic diseases.

  continue reading

94 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play